Values First Advisors’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

Values First Advisors’s Portfolio FRLN Stock Details FRLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,753	Closed	-$49K	–	163
2022 Q2	$49K	Buy	3,753 +410	+12%	+$5.27K	0.03%	150
2022 Q1	$56K	Buy	3,343 +1,806	+118%	+$33.5K	0.04%	157
2021 Q4	$46K	Buy	1,537 +142	+10%	+$5.8K	0.03%	165
2021 Q3	$71K	Buy	+1,395	New	+$99.2K	0.05%	141

Other funds holding FRLN

Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Values First Advisors's FRLN Position: Q3 2022 in Review

Values First Advisors sold out of Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) in Q3 2022, closing a stake of 3,753 shares — an estimated $49K sold.

Values First Advisors first reported a position in FRLN in Q3 2021 and held it in 4 quarters. The position peaked at $71K in Q3 2021. 14 funds tracked by Wall St. Rank hold FRLN as of Q3 2022.

Values First Advisors reported no remaining Freeline Therapeutics Holdings plc American Depositary Shares position as of Q3 2022 after selling out during the quarter.
Values First Advisors sold 3,753 Freeline Therapeutics Holdings plc American Depositary Shares shares in Q3 2022, an estimated $49K.
Values First Advisors first reported a position in Freeline Therapeutics Holdings plc American Depositary Shares in Q3 2021 and held it in 4 quarters.
Values First Advisors's Freeline Therapeutics Holdings plc American Depositary Shares position peaked at $71K in Q3 2021.
14 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings plc American Depositary Shares as of Q3 2022.

Based on Values First Advisors's 13F filing for Q3 2022, filed 2 Dec 2022.